Common Contracts
2 similar Acquisition Agreement contracts by Zynerba Pharmaceuticals, Inc.
ContractAcquisition Agreement • August 14th, 2023 • Zynerba Pharmaceuticals, Inc. • Pharmaceutical preparations
Standard Contracts
Good day,Acquisition Agreement • August 14th, 2023 • Zynerba Pharmaceuticals, Inc. • Pharmaceutical preparations
As announced this morning in a joint press release (attached), Harmony Biosciences Holdings, Inc. (“Harmony”), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, has entered into a definitive agreement to acquire Zynerba Pharmaceuticals, Inc. (“Zynerba”). The acquisition is intended to support Harmony’s goal of building a diversified portfolio of innovative assets that treat rare neuropsychiatric disorders. The transaction is expected to close by the fourth quarter of 2023, subject to customary closing conditions.
